Holen Sie sich die Stockscreener-App
9.45
1.06%
-0.101
Daxor Corporation Aktie (DXR) Neueste Nachrichten
Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World
(DXR) Long Term Investment Analysis - Stock Traders Daily
(DXR) On The My Stocks Page - Stock Traders Daily
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24 - The Manila Times
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC - GlobeNewswire
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Long Term Trading Analysis for (DXR) - Stock Traders Daily
Short Interest in Daxor Co. (NASDAQ:DXR) Rises By 39.6% - Defense World
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device - The Manila Times
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024 - GlobeNewswire
Daxor (NYSEAMERICAN:DXR) Stock Passes Above Two Hundred Day Moving Average of $0.00 - Defense World
(DXR) Technical Data - Stock Traders Daily
Daxor announces review published in journal on BVA - TipRanks
Newly Published Review Highlights the Pivotal Role of - GlobeNewswire
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management - StockTitan
Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets - Defense World
Daxor secures $300K from LaunchTN for blood analyzer tech - Investing.com India
Daxor receives $300K matching fund award from Launch Tennessee - TipRanks
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee - GlobeNewswire
DXRDaxor Corporation Latest Stock News & Market Updates - StockTitan
Central Florida hospital implements Daxor BVA-100 blood volume diagnostic - TipRanks
Leading Central Florida Hospital Implements Daxor’s - GlobeNewswire
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care - StockTitan
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter - GlobeNewswire
Daxor reports doubled revenue, secures government contracts - Investing.com
Daxor reports doubled revenue, secures government contracts By Investing.com - Investing.com Canada
Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time - TipRanks
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network - GlobeNewswire
Daxor (DXR) Owner Earnings per Share (TTM) : 0.00 (As of Dec. 2023) - GuruFocus.com
Daxor (NASDAQ:DXR) Stock Price Down 4.6% - Defense World
Daxor Corporation Awarded $1.9M Contract by The U.S. Air - GlobeNewswire
Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer - StockTitan
Daxor Expands to Three New Facilities as Blood Volume Analysis Technology Gains Momentum Nationwide - Marketscreener.com
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide - GlobeNewswire
Daxor Corporation Awarded New U.S. Defense Health Agency - GlobeNewswire
Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer - StockTitan
Daxor awarded $550K matching-fund extension from U.S. DHA - TipRanks
Daxor Corp holds annual meeting, re-elects directors By Investing.com - Investing.com Canada
Daxor Corp holds annual meeting, re-elects directors - Investing.com
(DXR) Trading Report - Stock Traders Daily
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide - GlobeNewswire
Daxor’s BVA-100 blood volume diagnostic expands to three new centers - TipRanks
Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume Analysis: New Data Presented at the American College of Cardiology Congress - Yahoo Movies UK
Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume ... - Yahoo Movies UK
Short Interest in Daxor Co. (NASDAQ:DXR) Grows By 15.2% - Defense World
Learn to Evaluate (DXR) using the Charts - Stock Traders Daily
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):